Photosensibilisierende Antihypertensiva und das Hautkrebsrisiko bei postmenopausalen Frauen: Photosensitizing antihypertensive medication and risk of skin cancer among postmenopausal women

Hintergrund

Es gibt nur wenige prospektive Studien, die die Dosis‐Wirkungs‐Beziehung zwischen der Anwendung einiger photosensibilisierender Antihypertensiva und Hautkrebs untersucht haben.

Patienten und Methodik

Anhand prospektiver Daten aus der Women's Health Initiative Observational Study untersuchten wir den Zusammenhang zwischen der Anwendung von Antihypertensiva und dem Risiko für nicht melanozytären Hautkrebs (NMSC) und dem Melanom bei postmenopausalen Frauen im Alter von 50–79 Jahren (n = 64 918). Dabei wurden multivariable Cox‐Regressionsmodelle (Proportional‐Hazard‐Modelle) verwendet und Hazard Ratios (HR) sowie 95%‐Konfidenzintervalle (KI) berechnet.

Ergebnisse

8777 NMSC und 1227 Melanom‐Fälle wurden beobachtet. Die Anwendung von Antihypertensiva (HR [95%‐KI]: 1,12 [1,07–1,18]), ACE‐Hemmern (1,09 [1,01–1,18]), Kalziumkanalblockern (1,13 [1,05–1,22]), Diuretika (1,20 [1,12–1,27]), Schleifendiuretika (1,17 [1,07–1,28]) und Thiaziden (1,17 [1,03–1,33]) war jeweils mit einem erhöhten NMSC‐Risiko assoziiert. Das NMSC‐Risiko stieg linear mit der Anwendung mehrerer Antihypertensiva (p‐Trend = 0,02) und mit zunehmender Anwendungsdauer (p‐Trend < 0,01) an. Antihypertensiva (1,15 [1,00–1,31]), Angiotensin‐II‐Rezeptorblocker (1,82 [1,05–3,15]) und Diuretika (1,34 [1,13–1,59]) waren jeweils mit einem erhöhten Melanomrisiko assoziiert. Zwischen der Anwendung von Antihypertensiva und der Melanom‐Inzidenz wurde eine Effektmodifikation durch Exposition gegenüber Sonnenlicht‐Exposition beobachtet (p‐Interaktion = 0,02).

Schlussfolgerungen

Die Anwendung von Antihypertensiva allgemein und einiger einzelner Klassen von Antihypertensiva ging mit einer erhöhten Inzidenz von NMSC und Melanomen einher, wobei eine Dosis‐Wirkungs‐Beziehung bestand.

Eye enucleation and exenteration in -cattle: a retrospective study of 38 cases (2013-2020)

INTRODUCTION

The study aimed to describe clinical indications for eye enucleation and exenteration, the occurrence of complications and long-term outcome in cattle, and examine owners' attitude towards enucleation and exenteration and their satisfaction with the surgical outcome. Medical records from the two veterinary teaching hospitals in Switzerland were reviewed to identify cattle that underwent unilateral enucleation or exenteration between January 2013 and December 2020. Data extracted included medical history, ocular examination, clinical diagnosis, surgical procedure including anesthesia, suture material and pattern used, complications, and treatment thereof. Long-term follow-up was evaluated via national animal database inquiries to determine survival time and via owners' interviews with the use of a standardized questionnaire that included questions regarding the occurrence of complications and reason for culling, production performances and perceived quality of life after surgery, concerns, factors affecting the decision to proceed with surgery, and general satisfaction with the outcome. Descriptive statistics, Fisher's exact tests and unpaired t-test were used to summarize the data and assess association between variables. Association was considered significant if p < 0,05. Thirty-eight cases were identified, with a median age of 5 years. More than half of the cases (55,3 %) were diagnosed with non-neoplastic ocular lesions represented by severe trauma with loss of globe content, globe rupture with history of infectious keratoconjunctivitis or hypopyon, or congenital malformations. The remaining cases were diagnosed with neoplastic lesions, including ocular squamous cell carcinoma (OSCC), melanoma, or sarcoma. Complications following surgery were reported in 29 % of cases and included postoperative infection and recurrence of OSCC. There was no significant association between ocular diagnosis and the occurrence of postoperative complications or survival time. Surgery did not seem to influence the animals' postoperative production performance or the perceived quality of life. Most owners (92 %) were satisfied with the surgical outcome. The occurrence of postoperative complications leading to increased overall costs and culling was the main reason for lower owner satisfaction.

[CME: Update Actinic Keratoses]

CME: Update Actinic Keratoses Abstract. Actinic keratoses (AKs) present as changes to the skin caused by chronic UVB damage. The warning signs are increased keratinization and dysplasia of epidermal cells. AKs can evolve into squamous cell carcinomas. The prevalence of this disease that affects areas of the skin exposed to sunlight increases with age. Diagnosis often takes the form of visual diagnosis. In cases of recurrence or doubt, histological confirmation should be sought. Various treatment options are available, ranging from the use of ablative to topical drug-based procedures. Prevention is very important. This article provides information on the clinical picture, assistance in identifying this disease, and therapeutic options.